AmebaGone Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $100K

  • Investors
  • 10

AmebaGone General Information

Description

Developer of amoebae technologies designed to destroy intractable bacterial infections in crops. The company uses naturally occurring free-living phagocytic dictyostelid cells and their secreted products as bio-control chemicals to kill bacteria, enabling agricultural farmers and industries to treat disease-causing bacteria in plants, humans, and the environment.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 505 South Rosa Road
  • Suite Number 15
  • Madison, WI 53719
  • United States
+1 (608)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 505 South Rosa Road
  • Suite Number 15
  • Madison, WI 53719
  • United States
+1 (608)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AmebaGone Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Grant 29-Sep-2020 $100K Completed Generating Revenue
10. Grant 31-Dec-2019 Completed Generating Revenue
9. Grant 01-Jan-2019 Completed Generating Revenue
8. Grant 31-Dec-2018 Completed Generating Revenue
7. Later Stage VC (Series A) 05-Oct-2018 Completed Generating Revenue
6. Later Stage VC 11-Sep-2018 Completed Generating Revenue
5. Later Stage VC 01-Mar-2016 Completed Generating Revenue
4. Debt - General 01-Jan-2016 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
2. Grant 01-Mar-2015 $721K Completed Startup
To view AmebaGone’s complete valuation and funding history, request access »

AmebaGone Patents

AmebaGone Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-12773430-B2 Anti-biofilm agents and uses thereof Active 23-Apr-2020
US-20210330715-A1 Anti-biofilm agents and uses thereof Active 23-Apr-2020
EP-4081230-A1 Therapeutic amoeba and uses thereof Inactive 23-Dec-2019
EP-4081230-A4 Therapeutic amoeba and uses thereof Inactive 23-Dec-2019
US-20230040339-A1 Therapeutic amoeba and uses thereof Inactive 23-Dec-2019 A01N63/10
To view AmebaGone’s complete patent history, request access »

AmebaGone Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AmebaGone Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Center for Technology Commercialization Government
Department of Primary Industries and Regional Development Government
National Institutes of Health Government
U.S. Department of Health and Human Services Government
United States Department of Agriculture Government
You’re viewing 5 of 10 investors. Get the full list »

AmebaGone FAQs

  • When was AmebaGone founded?

    AmebaGone was founded in 2010.

  • Where is AmebaGone headquartered?

    AmebaGone is headquartered in Madison, WI.

  • What is the size of AmebaGone?

    AmebaGone has 6 total employees.

  • What industry is AmebaGone in?

    AmebaGone’s primary industry is Biotechnology.

  • Is AmebaGone a private or public company?

    AmebaGone is a Private company.

  • What is AmebaGone’s current revenue?

    The current revenue for AmebaGone is .

  • How much funding has AmebaGone raised over time?

    AmebaGone has raised $10M.

  • Who are AmebaGone’s investors?

    The Center for Technology Commercialization, Department of Primary Industries and Regional Development, National Institutes of Health, U.S. Department of Health and Human Services, and United States Department of Agriculture are 5 of 10 investors who have invested in AmebaGone.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process